The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Piven V.D.

Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia

Krasnov V.S.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. akad. I.P. Pavlova, kafedra nevrologii s klinikoĭ;
Federal'nyĭ tsentr serdtsa, krovi i éndokrinologii im. V.A. Almazova, Sankt-Peterburg

Lashok P.A.

Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia

Neofidoff N.A.

Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia

Bubnova Е.V.

Neurology and Neurosurgery Chair and Clinic of the First Pavlov State Medical University of St. Petersburg of the Ministry of Health of the Russian Federation, Saint Petersburg, Russia

Totolian N.A.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. akad. I.P. Pavlova

Behcet’s disease with neurologic manifestations

Authors:

Piven V.D., Krasnov V.S., Lashok P.A., Neofidoff N.A., Bubnova Е.V., Totolian N.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(10): 67‑73

DOI: 10.17116/jnevro201911910167

Read: 14714 times

Download PDF (RU)
Contact the author
Table of contents

BEHCET’S DISEASE WITH NEUROLOGIC MANIFESTATIONS
BEHCET’S DISEASE WITH NEUROLOGIC MANIFESTATIONS

To cite this article:

Piven VD, Krasnov VS, Lashok PA, Neofidoff NA, Bubnova ЕV, Totolian NA. Behcet’s disease with neurologic manifestations. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(10):67‑73. (In Russ.)
https://doi.org/10.17116/jnevro201911910167

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Challenges of differential diagnosis in the veri­fication of Behçet’s disease with neurological mani­festations. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):108-113
Infi­ltrative-ulcerative lesion of the larynx in Behcet’s disease. Russian Bulletin of Otorhinolaryngology. 2025;(4):112-114
Biomarkers in tear fluid in uveitis. Russian Annals of Ophthalmology. 2025;(4):88-95
Abstract:

Behcet’s disease (BD) is a type of systematic chronic inflammatory disease of unknown etiology that is characterized by the combination of recurrent oral aphthous, genital ulcers and uveitis. A damage of the nervous system is observed in 3—9% of patients, in which two variants of the course of the disease are possible: parenchymal in the form of immune-mediated meningoencephalitis, and non-parenchymal, which can be represented by venous sinus thrombosis, intracranial arterial aneurysms and intracranial hypertension. The article presents a clinical case of BD with a dominant nervous system damage in the clinical presentations of the disease.

Keywords:

Behcet’s disease
uveitis
meningoencephalitis
aphthous ulcer

Authors:

Piven V.D.

Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia

Krasnov V.S.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. akad. I.P. Pavlova, kafedra nevrologii s klinikoĭ;
Federal'nyĭ tsentr serdtsa, krovi i éndokrinologii im. V.A. Almazova, Sankt-Peterburg

Lashok P.A.

Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia

Neofidoff N.A.

Pavlov First St. Petersburg State Medical University, St. Petersburg, Russia

Bubnova Е.V.

Neurology and Neurosurgery Chair and Clinic of the First Pavlov State Medical University of St. Petersburg of the Ministry of Health of the Russian Federation, Saint Petersburg, Russia

Totolian N.A.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. akad. I.P. Pavlova

Close metadata

References:

  1. Davatchi F, Assaad-Khalil S, Calamia K, Crook J, Sadeghi-Abdollahi B, Schirmer M, Tzellos T, Zouboulis C, Akhlagi M, Al-Dalaan A, Alekberova Z, Ali A, Altenburg A, Arromdee E, Baltaci M, Bastos M, Benamour S, Ben Ghorbel I, Boyva A, Carvalho L, Chen W, Ben-Chetrit E, Chams-Davatchi C, Correia J. A, Crespo J, Dias C, Dong Y, Paixão-Duarte F, Elmuntaser K, Elonakov A, Graña Gil J, Haghdoost A, Hayani, R, Houman H, Isayeva A, Jamshidi A, Kaklamanis P, Kumar A, Kyrgidis A, Madanat W, Nadji A, Namba K, Ohno S, Olivieri I, Vaz Patto J, Pipitone N, Queiroz M, Ramos F, Resende C, Rosa C, Salvarani C, Serra M, Shahram F, Shams H, Sharquie K, Sliti-Khanfir M, Tribolet de Abreu T, Vasconcelos C, Vedes J, Wechsler B, Cheng Y, Zhang Z, Ziaei N. The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. Journal of the European Academy of Dermatology and Venereology. 2013;28(3):338-347. https://doi.org/10.1111/jdv.12107
  2. Tüzün Y, Yurdakul S, Mat M, Özyazgan Y, Hamuryudan V, Tüzün B, Yazici H. Epidemiology of Behçet’s syndrome in Turkey. International Journal of Dermatology. 1996;35(9):618-620. https://doi.org/10.1111/j.1365-4362.1996.tb03683.x
  3. Verity D, Marr J, Ohno S, Wallace G, Stanford M. Behcet’s disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens. 1999;54(3):213-220. https://doi.org/10.1034/j.1399-0039.1999.540301.x
  4. Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M. Close Association of HLA-B*51 with Behcet’s Disease. Archives of Ophthalmology. 1982;100(9):1455-1458. https://doi.org/10.1001/archopht.1982.01030040433013
  5. Yazici H, Fresko I, Yurdakul S. Behçet’s syndrome: disease manifestations, management, and advances in treatment. Nature Clinical Practice Rheumatology. 2007;3(3):148-155. https://doi.org/10.1038/ncprheum0436
  6. Koné-Paut I, Geisler I, Wechsler B, Ozen S, Ozdogan H, Rozenbaum M, Touitou I. Familial aggregation in Behçet’s disease: High frequency in siblings and parents of pediatric probands. The Journal of Pediatrics. 1999;135(1):89-93. https://doi.org/10.1016/s0022-3476(99)70333-1
  7. Mizuki N, Inoko H, Ohno S. Molecular genetics (HLA) of BehÇet’s disease. Yonsei Medical Journal. 1997;38(6):333. https://doi.org/10.3349/ymj.1997.38.6.333
  8. Gul A, Ohno S. HLA-B*51 and Behçet Disease. Ocular Immunology and Inflammation. 2011;20(1):37-43. https://doi.org/10.3109/09273948.2011.634978
  9. Yazici H, Tuzun Y, Pazarli H, Yurdakul S, Ozyazgan Y, Ozdoğan H, Serdaroğlu S, Ersanli M, Ulkü BY, Müftüoğlu AU. Influence of age of onset and patient’s sex on the prevalence and severity of manifestations of Behcet’s syndrome. Annals of the Rheumatic Diseases. 1984;43(6):783-789. https://doi.org/10.1136/ard.43.6.783
  10. Zeidan M, Saadoun D, Garrido M, Klatzmann D, Six A, Cacoub P. Behçet’s disease physiopathology: a contemporary review. Autoimmunity Highlights. 2016;7(1). https://doi.org/10.1007/s13317-016-0074-1
  11. Nurieva R, Yang X, Martinez G, Zhang Y, Panopoulos A, Ma L, Schluns K, Tian Q, Watowich S, Jetten A, Dong C. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature. 2007;448(7152):480-483. https://doi.org/10.1038/nature05969
  12. Fantini M, Rizzo A, Fina D, Caruso R, Becker C, Neurath M, MacDonald T, Pallone F. IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells. European Journal of Immunology. 2007;37(11):3155-3163. https://doi.org/10.1002/eji.200737766
  13. Ekinci N, Alpsoy E, Karakas A, Yilmaz S, Yegin O. IL-17A Has an Important Role in the Acute Attacks of Behçet’s Disease. Journal of Investigative Dermatology. 2010;130(8):2136-2138. https://doi.org/10.1038/jid.2010.114
  14. Fujimori K, Oh-i K, Takeuchi M Yamakawa N, Hattori T, Kezuka T, Keino H, Suzuki J, Goto H, Sakai J, Usui M. Circulating neutrophils in Behçet disease is resistant for apoptotic cell death in the remission phase of uveitis. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2007;246(2):285-290. https://doi.org/10.1007/s00417-007-0659-5
  15. Caliskan M, Yilmaz S, Yildirim E, Gullu H, Erdogan D, Ciftci O, Kaynar G, Yucel E, Muderrisoglu H. Endothelial functions are more severely impaired during active disease period in patients with Behcet’s disease. Clinical Rheumatology. 2006;26(7):1074-1078. https://doi.org/10.1007/s10067-006-0449-1
  16. Saip S, Akman-Demir G, Siva A. Neuro-Behçet syndrome. Handbook of Clinical Neurology. 2004;121:1703-1723. https://doi.org/10.1016/b978-0-7020-4088-7.00110-3
  17. Kalra S, Silman A, Akman-Demir G, Bohlega S, Borhani-Haghighi A, Constantinescu CS, Houman H, Mahr A, Salvarani C, Sfikakis PP, Siva A, Al-Araji A. Diagnosis and management of Neuro-Behçet’s disease: international consensus recommendations. Journal of Neurology. 2013;261(9):1662-1676. https://doi.org/10.1016/j.jns.2013.07.2482
  18. Siva A, Altintas A, Saip S. Behcet’s syndrome and the nervous system. Current Opinion in Neurology. 2004;17(3):347-357. https://doi.org/10.1097/00019052-200406000-00017
  19. Hirohata S. Histopathology of central nervous system lesions in Behçet’s disease. Journal of the Neurological Sciences. 2008;267(1-2):41-47. https://doi.org/10.1016/j.jns.2007.09.041
  20. Al-Araji A, Kidd D. Neuro-Behçet’s disease: epidemiology, clinical characteristics, and management. The Lancet Neurology. 2009;8(2):192-204. https://doi.org/10.1016/s1474-4422(09)70015-8
  21. Akman-Demir G, Bahar S, Baykan-Kurt B, Gürvit I, Serdaroǧlu P. Intracranial hypertension in Behçet’s Disease. European Journal of Neurology. 1996;3(1):66-70. https://doi.org/10.1111/j.1468-1331.1996.tb00192.x
  22. Davatchi F, Sadeghi Abdollahi B, Chams-Davatchi C, Shahram F, Shams H, Nadji A, Faezi T, Akhlaghi M, Ghodsi Z, Mohtasham N, Ashofteh F. The saga of diagnostic/classification criteria in Behcet’s disease. International Journal of Rheumatic Diseases. 2015;18(6):594-605. https://doi.org/10.1111/1756-185x.12520
  23. Akman-Demir G, Serdaroglu P, Tasçi B. Clinical patterns of neurological involvement in Behçet’s disease: evaluation of 200 patients. Brain. 1999;122(11):2171-2182. https://doi.org/10.1093/brain/122.11.2171
  24. Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gul A, Kötter I, Leccese P, Mahr A, Moots R, Ozguler Y, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H. 2018 update of the EULAR recommendations for the management of Behçet’s syndrome. Annals of the Rheumatic Diseases. 2018;77(6):808-818. https://doi.org/10.1136/annrheumdis-2018-213225
  25. Ait Ben Haddou E, Imounan F, Regragui W, Mouti O, Benchakroune N, Abouqal R, Benomar A, Yahyaoui M. Neurological manifestations of Behçet’s disease: Evaluation of 40 patients treated by cyclophosphamide. Revue Neurologique. 2012;168(4):344-349. https://doi.org/10.1016/j.neurol.2011.09.006
  26. Borhani Haghighi A, Safari A, Nazarinia M, Habibagahi Z, Shenavandeh S. Infliximab for patients with neuro-Behcet’s disease: case series and literature review. Clinical Rheumatology. 2011;30(7):1007-1012. https://doi.org/10.1007/s10067-011-1726-1
  27. Fasano A, D’Agostino M, Caldarola G, Feliciani C, De Simone C. Infliximab monotherapy in Neuro-Behçet’s disease: Four year follow-up in a long-standing case resistant to conventional therapies. Journal of Neuroimmunology. 2011;239(1-2):105-107. https://doi.org/10.1016/j.jneuroim.2011.08.014
  28. Kaji M, Kishi T, Miyamae T, Nagata S, Yamanaka H, Fujikawa S. Efficacy of Adalimumab in a Girl with Refractory Intestinal Behcet’s Disease. Case Reports in Rheumatology. 2015;2015:1-5. https://doi.org/10.1155/2015/716138
  29. Alty J, Monaghan T, Bamford J. A patient with neuro-Behçet’s disease is successfully treated with etanercept: Further evidence for the value of TNFα blockade. Clinical Neurology and Neurosurgery. 2007;109(3):279-281. https://doi.org/10.1016/j.clineuro.2006.11.002
  30. Gurler A, Boyvat A, Tursen U. Clinical manifestations of BehÇet’s disease: an analysis of 2147 patients. Yonsei Medical Journal. 1997;38(6):423. https://doi.org/10.3349/ymj.1997.38.6.423
  31. Thiers B. Clinical features and natural course of Behçet’s disease in 661 cases: a multicentre study. Yearbook of Dermatology and Dermatologic Surgery. 2008;229-230. https://doi.org/10.1016/s0093-3619(08)70855-4
  32. Kidd D, Steuer A, Denman A, Rudge P. Neurological complications in Behçet’s syndrome. Brain. 1999;122(11):2183-2194. https://doi.org/10.1093/brain/122.11.2183
  33. Saip S, Siva A, Altintas A, Kiyat A, Seyahi E, Hamuryudan V, Yazici H. Headache in Behçet’s Syndrome. Headache: The Journal of Head and Face Pain. 2005;45(7):911-919. https://doi.org/10.1111/j.1526-4610.2005.05160.x
  34. Akman-Demir G, Saip S, Siva A. Behçet’s Disease. Current Treatment Options in Neurology. 2011;13(3):290-310. https://doi.org/10.1007/s11940-011-0120-2
  35. Siva A, Saip S. The spectrum of nervous system involvement in Behçet’s syndrome and its differential diagnosis. Journal of Neurology. 2009;256(4):513-529. https://doi.org/10.1007/s00415-009-0145-6
  36. Yesilot N, Mutlu M, Gungor O, Baykal B, Serdaroglu P, Akman-Demir G. Clinical characteristics and course of spinal cord involvement in Behçet’s disease. European Journal of Neurology. 2007;14(7):729-737. https://doi.org/10.1111/j.1468-1331.2007.01754.x
  37. Kikuchi H, Aramaki K, Hirohata S. Effect of infliximab in progressive Neuro-Behçet’s syndrome. Journal of the Neurological Sciences. 2008;272(1-2):99-105. https://doi.org/10.1016/j.jns.2008.05.002
  38. Aykutlu E, Baykan B, Serdaroǧlu P, Gökyiǧit A, Akman-Demir G. Epileptic Seizures in Behçet Disease. Epilepsia. 2002;43(8):832-835. https://doi.org/10.1046/j.1528-1157.2002.01102.x
  39. Appenzeller S, de Castro R, Queiroz L, Madegan L, Soledade C, Zanardi Vde A, Nucci A, Cendes F, Fernandes SR. Brain tumor-like lesion in Behçet disease. Rheumatology International. 2005;26(6):577-580. https://doi.org/10.1007/s00296-005-0082-3
  40. Schmolck H. Large thalamic mass due to neuro-Behcet disease. Neurology. 2005;65(3):436-436. https://doi.org/10.1212/01.wnl.0000179219.97769.6a
  41. Guak T, Kim Y, Park S, Kim J. Paroxysmal Focal Dystonia in Neuro-Behçet by a Small Ipsilateral Thalamic Lesion. European Neurology. 2002;47(3):183-184. https://doi.org/10.1159/000047979
  42. Bogdanova D, Milanov I, Georgiev D. Parkinsonian Syndrome as a Neurological Manifestation of Behcet’s Disease. Canadian Journal of Neurological Sciences. Journal Canadien des Sciences Neurologiques. 1998;25(01):82-85. https://doi.org/10.1017/s0317167100033552
  43. Kuriwaka R, Kunishige M, Nakahira H, Inoue H, Higashi T, Tokumoto Y, Mitsui T. Neuro-Behcet’s disease with chorea after remission of intestinal Behcet’s disease. Clinical Rheumatology. 2004;23(4). https://doi.org/10.1007/s10067-004-0897-4
  44. Voros G, Sandhu S, Pandit R. Acute Optic Neuropathy in Patients with Behçet’s Disease. Ophthalmologica. 2006;220(6):400-405. https://doi.org/10.1159/000095869
  45. Kermode A, Plant G, MacManus D, Kendall B, Kingsley D, Moseley I. Behcet’s disease with slowly enlarging midbrain mass on MRI: Resolution following steroid therapy. Neurology. 1989;39(9):1251-1251. https://doi.org/10.1212/wnl.39.9.1251
  46. Wechsler B, Dell’lsola B, Vidailhet M, Dormont D, Piette JC, Blétry O, Godeau P. MRI in 31 patients with Behcet’s disease and neurological involvement: prospective study with clinical correlation. Journal of Neurology, Neurosurgery & Psychiatry. 1993;56(7):793-798. https://doi.org/10.1136/jnnp.56.7.793
  47. Akman-Demir G, Bahar S, Coban O, Tasci B, Serdaroglu P. Cranial MRI in Behcet’s disease: 134 examinations of 98 patients. Neuroradiology. 2003;45(12):851-859. https://doi.org/10.1007/s00234-003-1102-1
  48. Öktem-TanÖr Ö, Baykan-Kurt B, Gürvit I, Akman-Demir G, Serdaroğlu P. Neuropsychological follow-up of 12 patients with neuro-Behçet disease. Journal of Neurology. 1999;246(2):113-119. https://doi.org/10.1007/s004150050317
  49. Noel N, Bernard R, Wechsler B, Resche-Rigon M, Depaz R, Le Thi Huong Boutin D, Piette JC, Drier A, Dormont D, Cacoub P, Saadoun D. Long-Term Outcome of Neuro-Behçet’s Disease. Arthritis & Rheumatology. 2014;66(5):1306-1314. https://doi.org/10.1002/art.38351
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.